Casi Pharmaceuticals Offers Sale of 3M Ordinary Shares - NASDAQ:CASI
Friday, 16 August 2024, 21:24
Casi Pharmaceuticals Announces Sale of Shares
Casi Pharmaceuticals has officially filed to sell 3 million ordinary shares aimed at its current holders. This is a pivotal decision for Casi Pharmaceuticals and potential investors as the company works to enhance its market position.
Details of the Offer
- Total shares being offered: 3 million
- Targeted investors: Current shareholders
- Stock symbol: NASDAQ:CASI
With this offer, Casi Pharmaceuticals seeks to stimulate interest and boost liquidity among its investor base.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.